OrthoPediatrics (NASDAQ: KIDS)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.370 | -0.300 | 0.0700 | ||||
REV | 22.750M | 23.417M | 667.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of OrthoPediatrics (NASDAQ: KIDS) through any online brokerage.
Other companies in OrthoPediatrics’s space includes: RxSight (NASDAQ:RXST), Meihua International (NASDAQ:MHUA), Meridian Bioscience (NASDAQ:VIVO), BioLife Solns (NASDAQ:BLFS) and Embecta (NASDAQ:EMBC).
The latest price target for OrthoPediatrics (NASDAQ: KIDS) was reported by Needham on Thursday, May 5, 2022. The analyst firm set a price target for 59.00 expecting KIDS to rise to within 12 months (a possible 37.53% upside). 5 analyst firms have reported ratings in the last year.
The stock price for OrthoPediatrics (NASDAQ: KIDS) is $42.9 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for OrthoPediatrics.
OrthoPediatrics’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for OrthoPediatrics.
OrthoPediatrics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.